title: [Plasma protein derivatives].
abstract: Plasma protein derivatives produced from human plasma include albumin, blood coagulation factors, immuno globulins, haptoglobin, and c1-inactivator and have been widely used clinically. However, the HIV-tainted blood scandal in which HIV was transmitted to many Japanese patients through blood coagulation factors, must be remembered. The safety of blood products has increased since then in response to that event. Because blood products are provided by volunteer donors, there is a risk of contamination by unknown pathogens and they must be used appropriately. In addition, blood products including plasma derivatives are defined as "special biological products" and regulated by the new Medicine Act. All physicians who prescribe plasma derivatives should understand not only their clinical use but also social expectations and legal regulations.
authors.affiliation: The division of transfusion and cell Therapy, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan.
authors.forename: Kiyoshi
authors.initials: K
authors.lastname: Hiruma
mesh_terms: D001688:Biological Products; D001798:Blood Proteins / Q000008:administration & dosage / Q000600:supply & distribution; D001803:Blood Transfusion / Q000331:legislation & jurisprudence / Q000379:methods; D017848:Blood-Borne Pathogens; D006801:Humans; D012449:Safety; D065227:Transfusion Reaction; D014777:Virus Diseases / Q000517:prevention & control / Q000635:transmission
chemical_list: D001688:Biological Products; D001798:Blood Proteins